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Fractures (particularly osteoporotic fractures) among the aging population constitute a 
substantial public health burden. They are a major cause of disability, morbidity, reduction in 
health-related quality of life, mortality and are associated with increased costs to healthcare 
systems.1 The role of regular physical activity in the prevention of vascular disease, other chronic 
diseases and mortality is very well established.2,3 Epidemiological data also suggests that 
physical activity is associated with reduced fracture risk.4 Cardiorespiratory fitness (CRF) 
measured by maximal oxygen uptake (VO2max), is the gold standard for assessing aerobic 
capacity and is an indicator of habitual physical activity.5 Like physical activity, a wealth of 
epidemiologic evidence consistently shows CRF to be independently and inversely associated 
with adverse vascular outcomes, other chronic diseases and mortality.5,6 One of the pathways by 
which physical activity reduces fracture risk is by increasing or maintaining bone mineral density 
(BMD).7 A limited number of studies have reported increased levels of CRF to be associated 
with reduced risk for low BMD;8,9 however, whether this translates to a reduced risk of fractures 
is uncertain. The association between objectively measured CRF and future risk of fractures is 
unknown. In this context, we sought to investigate the prospective association between 




Reporting of the study conforms to broad EQUATOR guidelines10 and was conducted according 
to STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines 




analysis employed the Kuopio Ischemic Heart Disease (KIHD) risk factor study, a general 
population-based prospective cohort study that was set up to investigate risk factors primarily for 
cardiovascular disease (CVD) and other chronic diseases including osteoporotic fractures. The 
study design, recruitment methods, risk marker assessment and physical examinations have been 
described previously.11 Briefly, the KIHD cohort comprised a representative sample of middle-
aged men aged 42-61 years randomly recruited from a population register eastern Finland. The 
baseline cohort comprised of 2,682 eligible men who had baseline measurements performed 
between March 1984 and December 1989. In this analysis, complete information on CRF, 
relevant confounders, and fracture events was available for 2,173 men. The study research 
protocol was approved by the Research Ethics Committee of the University of Kuopio 
(December 1, 1983) and each participant gave written informed consent according to the 
Declaration of Helsinki. Maximal oxygen uptake was used as a measure of CRF and was 
estimated using a respiratory gas exchange analyzer during cycle ergometer exercise tests, which 
has been reported in detail previously.5 As a result of aging, disease, lifestyle changes and 
measurement errors in exposure estimation in prospective cohort studies with long-term follow-
up, analysis using only baseline measurements of an exposure could underestimate the true 
strength of any association between exposure and outcome (known as “regression dilution 
bias”5). To correct for this regression dilution bias, we used repeat measurements of VO2max 
taken 11 years apart in a random subset of 560 men to estimate the regression dilution ratio 
(RDR). The outcome assessed was any fracture (defined as hip, humeral, or wrist fractures) that 
occurred from study entry to 2014. Data on incident fractures was collected from the National 
Hospital Discharge Register data (maintained by the Finnish Institute for Health and Welfare) by 




of hospital records, discharge diagnoses, and inpatient physician claims. No losses to follow-up 
have so far been recorded. The events were coded by independent physicians according to the 
International Classification of Diseases Tenth Revision diagnostic codes for fractures by site. 
Cox proportional hazard regression models were used to calculate hazard ratios (HRs) with 95% 
confidence intervals (CIs). All statistical analyses were conducted using Stata version MP 16 
(Stata Corp, College Station, Texas). 
 
Results 
The overall mean [standard deviation (SD)] age and CRF of study participants at baseline were 
53 (5) years and 30.3 (8.0) mL/(kg.min) respectively (Table 1). The mean (SD) or CRF in the 
randomly selected sample who had repeat measurements 11 years after baseline was 27.6 (10.0) 
mL/(kg.min).  
During a median (interquartile range) follow-up of 25.9 (18.1-27.9) years, a total of 113 
fractures (annual rate 2.33/1,000 person-years at risk; 95% CI: 1.94 to 2.80) occurred. There 
were 68 hip fractures, representing an annual rate of 1.40/1,000 person-years at risk; 95% CI: 
1.11 to 1.78. A restricted cubic spline curve of the association between CRF and fracture risk 
was potentially consistent with a linear shape (p-value for non-linearity=0.21) with a threshold 
value;  the risk of fracture potentially decreased with increasing CRF from 6.4 to 27.4 
mL/(kg.min), with no potential decrease in risk of fracture thereafter (Figure 1). The HR (95% 
CI) for fractures per 1 SD increase in CRF was 0.82 (0.66–1.01) on adjustment for age which 
was minimally attenuated on further adjustment for several established risk factors and other 
potential confounders (systolic blood pressure, prevalent coronary heart disease (CHD), smoking 




consumption, serum ionized calcium, and high sensitivity C-reactive protein) (Table 2). When 
the top tertile of CRF was compared to the bottom tertile, the corresponding adjusted HRs (95% 
CIs) were 0.78 (0.48–1.25) and 0.92 (0.55–1.53) respectively. The overall age-adjusted RDR of 
CRF was 0.58 (95% CI: 0.53-0.64), which suggests that if there was a significant association 
between CRF and fracture risk, using baseline measurements of CRF could under-estimate the 
risk by [(1/0.58)-1]*100 = 72%. The HRs were more extreme after correction for regression 
dilution bias (Table 2).  
 
Discussion 
Given existing evidence on the role of CRF in preventing chronic diseases and reducing 
the risk of low BMD,5,8,9 we hypothesized that CRF may be linked to a reduced risk of fractures. 
In this first evaluation of the prospective association between objectively measured CRF and 
future risk of fractures in a middle-aged Caucasian male population, we found no significant 
evidence of an association. The annual incidence rate of hip fractures as at 2014 was 
140.5/100,000 person-years, which is broadly in line with estimates reported by an analysis of a 
nationwide database within the period 1970-2016.12 Kannus and colleagues12 in analyses of the 
trend in the number and incidence of hip fracture in persons of 50 years and older demonstrated a 
decline in the incidence of hip fractures; the incidence in men was 256.5 per 100,000 persons in 
1997 and fell to 194.7 in 2016. 
Several important factors such as ageing, sex, heritability, physical activity, hormonal 
factors and nutrition are known to play a role in bone health and the development of fractures. 
Given that CRF is an objective marker of physical activity and may be used to define the 




Cardiorespiratory fitness is a modifiable risk factor that can be enhanced through regular aerobic 
physical activity. The level of CRF attained also depends on baseline health and fitness status of 
the individual, type, duration, and intensity of physical activity.13  However, genetics and other 
environmental factors also play an important part in influencing CRF levels. It has been reported 
that about half of the variation in CRF is attributed to heritability, with the contribution of 
inherited factors to the response of CRF to physical activity accounting for approximating 45-
50%.13 Hence, our null findings may reflect differences between physical activity and CRF in the 
pathophysiology of fractures. Previous studies reporting a reduced risk of low BMD with CRF 
have mostly been based in relatively younger populations.8,9 Whereas, studies conducted in 
middle-aged populations have demonstrated no evidence of an association between CRF and 
BMD.14,15 Given that our study was based on a middle-aged population, the evidence suggests 
that it is unlikely that aerobic activity commenced during middle age will have an effect on BMD 
and subsequently fractures. Other reasons for the null findings could be related to study design 
factors and population characteristics such as (i) low statistical power due to the low fracture 
event rate; (ii) unmeasured confounding; and (iii) age, sex, or genetic background of the 
population. Finally, given the optimal CRF levels in our cohort which appeared to be maintained 
after 11 years of follow-up, there is a possibility that aerobic activity beyond a certain threshold 
may not have a beneficial effect on bone health. Indeed, in our assessment of the potential shape 
of the association between CRF and fracture risk assuming there was significant evidence of an 
association, the risk of fracture potentially decreased with increasing CRF from 6.4 to 27.4 
mL/(kg.min), beyond which there was no further decrease. There is absence of previous 




is required to assess the nature of any potential dose-relationship between CRF and fracture risk, 
especially in other populations and age groups. 
The strengths of the present analysis include the new findings, the large-scale population-
based representative sample, prospective cohort design and long-term follow-up, objectively 
measured CRF, and repeat measurements of CRF which allowed for quantification of regression 
dilution. Important limitations worthy of mention include the low event rate which also 
precluded evaluation of specific fracture sites, lack of generalisation of findings to women and 
other age groups, and lack of data on fractures related to falls or fall-related hospitalizations. We 
acknowledge the potential for selection bias given that study participants provided informed 
consent and this may potentially bias the results; however, this is an inherent limitation of 
observational cohort designs. 
 
Conclusion 
In summary, objectively measured CRF was not associated with future risk of fractures in a 
middle-aged general Caucasian population, suggesting that CRF may not play an important role 
in the pathogenesis of fractures in this population setting. Other large-scale studies are warranted 
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Table 1. Baseline participant characteristics 
 
  
Mean (SD), median (IQR), or 
n (%) 
Baseline CRF, mL/(kg.min) 30.3 (8.0) 
Repeat CRF at 11 years, mL/(kg.min) 27.6 (10.0) 
  
Questionnaire/Prevalent conditions  
Age at survey (years) 53 (5) 
Alcohol consumption (g/week) 32.0 (6.4-92.9) 
Socioeconomic status 8.38 (4.24) 
History of type 2 diabetes 73 (3.4) 
Current smokers 689 (31.7) 
History of CHD 515 (23.7) 
History of hypertension 647 (29.8) 
  
Physical measurements  
BMI (kg/m2) 26.9 (3.5) 
SBP (mmHg) 134 (17) 
DBP (mmHg) 89 (10) 
Total physical activity (kj/day) 1,213 (637-2,000) 
  
Blood-based markers  
Total cholesterol (mmol/l) 5.90 (1.06) 
HDL-C (mmol/l) 1.29 (0.30) 
Fasting plasma glucose (mmol/l) 5.33 (1.21) 
High sensitivity CRP (mg/l) 1.24 (0.69-2.37) 
Serum ionized calcium (mmol/l) 1.18 (0.05) 
 
BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; CRF, cardiorespiratory fitness;  
CRP, C-reactive protein; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol;  




Table 2. Association between cardiorespiratory fitness and risk of fractures 
 
CRF (mL/(kg.min)) Events/ 
Total 
Model 1  Model 2  
  HR (95% CI) P-value HR (95% CI) P-value 
Baseline CRF 
Per 1 SD increase 113 / 2,173 0.82 (0.66 to 1.01) 0.06 0.88 (0.70 to 1.10) 0.27 
T1 (6.36-26.86) 38 / 725 ref  ref  
T2 (26.87-33.24) 39 / 724 0.87 (0.55 to 1.36) 0.53 0.98 (0.62 to 1.57) 0.95 
T3 (33.25-65.40) 36 / 724 0.78 (0.48 to 1.25) 0.30 0.92 (0.55 to 1.53) 0.74 
Usual CRF* 
Per 1 SD increase 113 / 2,173 0.71 (0.49 to 1.02) 0.06 0.80 (0.54 to 1.19) 0.27 
T1 (6.36-26.86) 38 / 725 ref  ref  
T2 (26.87-33.24) 39 / 724 0.78 (0.36 to 1.70) 0.53 0.97 (0.44 to 2.17) 0.95 
T3 (33.25-65.40) 36 / 724 0.65 (0.28 to 1.48) 0.30 0.86 (0.36 to 2.08) 0.74 
 
CI, confidence interval; CRF, cardiorespiratory fitness; HR, hazard ratio; ref, reference; SD, standard deviation; T, tertile 
*, indicates correction for within-person variability in values of CRF, that is, the extent to which an individual’s CRF 
measurements vary around a long-term average value (“usual CRF values”) 
Model 1: Adjusted for age  
Model 2: Model 1 plus systolic blood pressure, prevalent coronary heart disease, smoking status, history of type 2 diabetes, total 
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